All
Search
Images
Videos
Shorts
Maps
News
More
Shopping
Flights
Travel
Notebook
Report an inappropriate content
Please select one of the options below.
Not Relevant
Offensive
Adult
Child Sexual Abuse
Length
All
Short (less than 5 minutes)
Medium (5-20 minutes)
Long (more than 20 minutes)
Date
All
Past 24 hours
Past week
Past month
Past year
Resolution
All
Lower than 360p
360p or higher
480p or higher
720p or higher
1080p or higher
Source
All
Dailymotion
Vimeo
Metacafe
Hulu
VEVO
Myspace
MTV
CBS
Fox
CNN
MSN
Price
All
Free
Paid
Clear filters
SafeSearch:
Moderate
Strict
Moderate (default)
Off
Filter
Mechanism of Action & Potential Impact of Tislelizumab | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
6 months ago
targetedonc.com
Foundations of cGVHD Diagnosis and Severity Assessment | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
3 months ago
targetedonc.com
Managing Toxicity and the Importance of Multidisciplinary Care | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1 month ago
targetedonc.com
Dr Michael Wang Traces MCL Therapy Evolution Before CAR T | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
4 weeks ago
targetedonc.com
Long-Term ECHO Data Support Concurrent Acalabrutinib/BR in MCL | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
5 months ago
targetedonc.com
MajesTEC-3 Trial Results - Efficacy and Safety Profile of Teclistamab-Daratumumab | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1 month ago
targetedonc.com
Case Presentation: A 72-Year-Old Woman With Metastatic Colorectal Cancer | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
Oct 4, 2021
targetedonc.com
Case Presentation: A 57-Year-Old Woman With Ovarian Cancer | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
Sep 23, 2021
targetedonc.com
Drawing Comparisons for Relevant Therapies in Patients With DLBCL | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
Dec 9, 2024
targetedonc.com
Understanding JZP898: A Breakthrough mRNA Therapy for Solid Tumors | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
Aug 16, 2024
targetedonc.com
Risk of Recurrence in Stage 3B CRC | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
Oct 7, 2016
targetedonc.com
Choosing Between Atezolizumab and Pembrolizumab in Lung Cancer | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
Jul 2, 2018
targetedonc.com
ELCC 2026: TOP Study, Sac-TMT, and the Future of EGFR-Mutant NSCLC | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1 month ago
targetedonc.com
A 52-Year-Old Woman With HER2-Positive Breast Cancer | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
May 22, 2019
targetedonc.com
The Targeted Pulse: Two Breakthrough Therapy Designations in Breast Cancer and NSCLC, FDA Approvals, and More | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
Jun 2, 2024
targetedonc.com
GIST: Treatment Considerations | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
Jun 22, 2020
targetedonc.com
Managing Disease Progression After TACE | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
Mar 10, 2025
targetedonc.com
Case 3: Essential Thrombocythemia (ET) | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
May 27, 2021
targetedonc.com
Challenges in Non-Small Cell Lung Cancer Treatment: Addressing Unmet Needs | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
Oct 16, 2023
targetedonc.com
NCCN Guidelines for Castleman's Disease | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
Oct 31, 2016
targetedonc.com
Targeting PIK3CA Mutations in Breast Cancer | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
Aug 12, 2023
targetedonc.com
Secondary Erythrocytosis Management: Differentiated Approach and Considerations | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
11 months ago
targetedonc.com
Multiple Myeloma Treatment: New Therapies vs Stem Cell Transplant | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
Apr 3, 2024
targetedonc.com
Safety Challenges of Oncolytic Virus Therapy | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
Jun 12, 2024
targetedonc.com
Evaluating Belzutifan for Clear Cell Renal Cell Carcinoma Treatment | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
Dec 15, 2024
targetedonc.com
Belumosudil Shows Sustained Efficacy and Safety for Chronic GVHD | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
Mar 11, 2024
targetedonc.com
Immunotherapy Advances in Small Cell Lung Cancer Treatment | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
Mar 6, 2025
targetedonc.com
Nirogacestat Shows Statistically Significant Improvements in Desmoid Tumors | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
Nov 28, 2023
targetedonc.com
Evolving Treatment Landscape in Metastatic Castration-Resistant Prostate Cancer (mCRPC) | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
11 months ago
targetedonc.com
The Differences Between mCRPC and nmCRPC | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
Jul 17, 2019
targetedonc.com
See more
More like this
Feedback
